US$ 23.83
retatrutide definition What Is Retatrutide? | Research-Use Explanation Retatrutide Peptide: Triple Agonist Mechanism,
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] Gong N, Xiao Q, Zhu B, Zhang CY, Wang YC, Fan H, Ma AN, Wang YX

The drug is being developed by Eli Lilly and Company, which has announced plans to progress retatrutide into Phase 3 clinical trials across multiple indications, including obesity, type 2 diabetes, and liver disease

This additional glucagon receptor activity is thought to further increase energy expenditure and promote hepatic fat reduction, though its precise contribution in humans is still under investigation

Early real-world evidence studies have already begun to confirm a consistent reduction of HHF with SGLT2 inhibitors, and ongoing studies are set to provide more comprehensive insights [73]
